Glenmark Pharmaceuticals Limited announced that Mr. Sridhar Gorthi, Mr. Devendra Raj Mehta, Mr. Brian Tempest and Mr. Bernard Munos have retired as Independent Directors of the Company from end of the day on 31st March, 2024, consequent to the completion of their second term of office as Independent Directors. Consequent to the aforesaid retirement, the following committees of the Board have been re-constituted as under: Committees of the Board Audit Committee Mr. Rajesh V. Desai ? Chairman, Mrs. Vijayalakshmi Iyer ?

Member, Ms. Saira Ramasastry ? Member. Stakeholders Relationship Committee Mr. Rajesh V. Desai ?

Chairman, Mrs. Cherylann Pinto ? Member, Ms. Saira Ramasastry ? Member.

Risk Management Committee Mr. Glenn Saldanha ­ Chairman, Mr. Rajesh V. Desai ­ Member, Mr. Dipankar Bhattacharjee ­ Member, Mr. V.S. Mani ­ Member. Nomination and Remuneration Committee Mr. Dipankar Bhattacharjee ­ Chairman, Mr. Glenn Saldanha ­ Member, Mrs. Vijayalakshmi Iyer ? Member.

Corporate Social Responsibility Committee Mrs. Cherylann Pinto ? Chairperson, Mrs. Vijayalakshmi Iyer ? Member, Mr. Rajesh V. Desai ­ Member.